Clinical Trials Browser

Phase 3 × Cholangiocarcinoma × ivosidenib × Clear all

NCT05876754 2026-02-19

ProvIDHe

Phase 3 Recruiting

Gastrointestinal

Cholangiocarcinoma

NCT02989857 2024-08-20

ClarIDHy

Phase 3 Completed

187 enrolled 34 charts 1 FDA

Gastrointestinal

Cholangiocarcinoma